163 related articles for article (PubMed ID: 27499075)
1. Investigation of the functional role of human Interleukin-8 gene haplotypes by CRISPR/Cas9 mediated genome editing.
Benakanakere MR; Finoti LS; Tanaka U; Grant GR; Scarel-Caminaga RM; Kinane DF
Sci Rep; 2016 Aug; 6():31180. PubMed ID: 27499075
[TBL] [Abstract][Full Text] [Related]
2. The ATC/TTC haplotype in the Interleukin 8 gene in response to Gram-negative bacteria: A pilot study.
Pigossi SC; Anovazzi G; Finoti LS; de Medeiros MC; de Souza-Moreira TM; Mayer MPA; Zanelli CF; Valentini SR; Rossa Junior C; Scarel-Caminaga RM
Arch Oral Biol; 2019 Nov; 107():104508. PubMed ID: 31382162
[TBL] [Abstract][Full Text] [Related]
3. Haplotypes of susceptibility to chronic periodontitis in the Interleukin 8 gene do not influence protein level in the gingival crevicular fluid.
Corbi SC; Anovazzi G; Finoti LS; Kim YJ; Capela MV; Secolin R; Marcaccini AM; Gerlach RF; Orrico SR; Cirelli JA; Scarel-Caminaga RM
Arch Oral Biol; 2012 Oct; 57(10):1355-61. PubMed ID: 22877792
[TBL] [Abstract][Full Text] [Related]
4. Haplotypes in the interleukin 8 gene and their association with chronic periodontitis susceptibility.
Scarel-Caminaga RM; Kim YJ; Viana AC; Curtis KM; Corbi SC; Sogumo PM; Orrico SR; Cirelli JA
Biochem Genet; 2011 Jun; 49(5-6):292-302. PubMed ID: 21188496
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes of periodontal therapy are not influenced by the ATC/TTC haplotype in the IL8 gene.
Corbi SC; Finoti LS; Anovazzi G; Tanaka MH; Kim YJ; Secolin R; Marcaccini AM; Gerlach RF; Orrico SR; Cirelli JA; Scarel-Caminaga RM
J Periodontal Res; 2014 Aug; 49(4):489-98. PubMed ID: 24033189
[TBL] [Abstract][Full Text] [Related]
6. Efficient SSA-mediated precise genome editing using CRISPR/Cas9.
Li X; Bai Y; Cheng X; Kalds PGT; Sun B; Wu Y; Lv H; Xu K; Zhang Z
FEBS J; 2018 Sep; 285(18):3362-3375. PubMed ID: 30085411
[TBL] [Abstract][Full Text] [Related]
7. Functional haplotype in the Interleukin8 (CXCL8) gene is associated with type 2 Diabetes Mellitus and Periodontitis in Brazilian population.
Silva BRD; Cirelli T; Nepomuceno R; Theodoro LH; Orrico SRP; Cirelli JA; Barros SP; Scarel-Caminaga RM
Diabetes Metab Syndr; 2020; 14(6):1665-1672. PubMed ID: 32905938
[TBL] [Abstract][Full Text] [Related]
8. Single nucleotide polymorphism and haplotype association of the interleukin-8 gene with nasopharyngeal carcinoma.
Wei YS; Lan Y; Tang RG; Xu QQ; Huang Y; Nong HB; Huang WT
Clin Immunol; 2007 Dec; 125(3):309-17. PubMed ID: 17720627
[TBL] [Abstract][Full Text] [Related]
9. Genome Engineering for Stem Cell Transplantation.
Argani H
Exp Clin Transplant; 2019 Jan; 17(Suppl 1):31-37. PubMed ID: 30777520
[TBL] [Abstract][Full Text] [Related]
10. CRISPR/Cas9-mediated genome editing of splicing mutation causing congenital hearing loss.
Ryu N; Kim MA; Choi DG; Kim YR; Sonn JK; Lee KY; Kim UK
Gene; 2019 Jun; 703():83-90. PubMed ID: 30898719
[TBL] [Abstract][Full Text] [Related]
11. A Single-Chain Photoswitchable CRISPR-Cas9 Architecture for Light-Inducible Gene Editing and Transcription.
Zhou XX; Zou X; Chung HK; Gao Y; Liu Y; Qi LS; Lin MZ
ACS Chem Biol; 2018 Feb; 13(2):443-448. PubMed ID: 28938067
[TBL] [Abstract][Full Text] [Related]
12. Development of a CRISPR/Cas9 genome editing toolbox for Corynebacterium glutamicum.
Liu J; Wang Y; Lu Y; Zheng P; Sun J; Ma Y
Microb Cell Fact; 2017 Nov; 16(1):205. PubMed ID: 29145843
[TBL] [Abstract][Full Text] [Related]
13. Manipulating the Biosynthesis of Bioactive Compound Alkaloids for Next-Generation Metabolic Engineering in Opium Poppy Using CRISPR-Cas 9 Genome Editing Technology.
Alagoz Y; Gurkok T; Zhang B; Unver T
Sci Rep; 2016 Aug; 6():30910. PubMed ID: 27483984
[TBL] [Abstract][Full Text] [Related]
14. Enhancing CRISPR/Cas9-mediated homology-directed repair in mammalian cells by expressing Saccharomyces cerevisiae Rad52.
Shao S; Ren C; Liu Z; Bai Y; Chen Z; Wei Z; Wang X; Zhang Z; Xu K
Int J Biochem Cell Biol; 2017 Nov; 92():43-52. PubMed ID: 28928041
[TBL] [Abstract][Full Text] [Related]
15. Efficient oligo nucleotide mediated CRISPR-Cas9 gene editing in Aspergilli.
Nødvig CS; Hoof JB; Kogle ME; Jarczynska ZD; Lehmbeck J; Klitgaard DK; Mortensen UH
Fungal Genet Biol; 2018 Jun; 115():78-89. PubMed ID: 29325827
[TBL] [Abstract][Full Text] [Related]
16. Chromatin accessibility and guide sequence secondary structure affect CRISPR-Cas9 gene editing efficiency.
Jensen KT; Fløe L; Petersen TS; Huang J; Xu F; Bolund L; Luo Y; Lin L
FEBS Lett; 2017 Jul; 591(13):1892-1901. PubMed ID: 28580607
[TBL] [Abstract][Full Text] [Related]
17. CRISPR-Cas immunity, DNA repair and genome stability.
Cubbon A; Ivancic-Bace I; Bolt EL
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30209206
[TBL] [Abstract][Full Text] [Related]
18. CRISPR/Cas9-mediated correction of human genetic disease.
Men K; Duan X; He Z; Yang Y; Yao S; Wei Y
Sci China Life Sci; 2017 May; 60(5):447-457. PubMed ID: 28534256
[TBL] [Abstract][Full Text] [Related]
19. Exploring the potential of genome editing CRISPR-Cas9 technology.
Singh V; Braddick D; Dhar PK
Gene; 2017 Jan; 599():1-18. PubMed ID: 27836667
[TBL] [Abstract][Full Text] [Related]
20. Design and Validation of CRISPR/Cas9 Systems for Targeted Gene Modification in Induced Pluripotent Stem Cells.
Lee CM; Zhu H; Davis TH; Deshmukh H; Bao G
Methods Mol Biol; 2017; 1498():3-21. PubMed ID: 27709565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
